Naftifine Hydrochloride Patent Expiration

Naftifine Hydrochloride is Used for treating fungal infections. It was first introduced by Sebela Ireland Ltd in its drug Naftin on Feb 29, 1988. 4 different companies have introduced drugs containing Naftifine Hydrochloride.


Naftifine Hydrochloride Patents

Given below is the list of patents protecting Naftifine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Naftin US10166205 Topical compositions and methods for making and using same Jan 31, 2033 Sebela Ireland Ltd
Naftin US10166206 Topical compositions and methods for making and using same Jan 31, 2033 Sebela Ireland Ltd
Naftin US10695303 Topical compositions and methods for making and using same Jan 31, 2033 Sebela Ireland Ltd
Naftin US10729667 Topical compositions and methods for making and using same Jan 31, 2033 Sebela Ireland Ltd
Naftin US8778365 Topical compositions and methods for making and using same Jan 31, 2033 Sebela Ireland Ltd
Naftin US9161914 Topical compositions and methods for making and using same Jan 31, 2033 Sebela Ireland Ltd


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Naftifine Hydrochloride Generics

Several generic applications have been filed for Naftifine Hydrochloride. The first generic version for Naftifine Hydrochloride was by Taro Pharmaceuticals Inc and was approved on Jan 6, 2016. And the latest generic version is by Xiromed Pharma Espana Sl and was approved on Sep 22, 2020.

Given below is the list of companies who have filed for Naftifine Hydrochloride generic.


1. XIROMED

Xiromed Pharma Espana Sl has filed for 1 generic for Naftifine Hydrochloride. Given below are the details of the strengths of this generic introduced by Xiromed.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2% cream Prescription TOPICAL AB Sep 22, 2020


2. TARO

Taro Pharmaceuticals Inc has filed for 2 different strengths of generic version for Naftifine Hydrochloride. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2% gel Prescription TOPICAL AB Apr 10, 2019
1%

(reference standard)

cream Prescription TOPICAL N/A Sep 8, 2016


3. AMNEAL

Amneal Pharmaceuticals Llc has filed for 2 different strengths of generic version for Naftifine Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2% cream Prescription TOPICAL AB Apr 10, 2017
1% gel Prescription TOPICAL AB Mar 20, 2019